5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.50▲ | 1.52▼ | 1.54▼ | 1.69▼ | 1.71▼ |
MA10 | 1.50▲ | 1.54▼ | 1.58▼ | 1.71▼ | 2.03▼ |
MA20 | 1.51▲ | 1.59▼ | 1.67▼ | 1.76▼ | 2.96▼ |
MA50 | 1.54▼ | 1.70▼ | 1.74▼ | 2.23▼ | 3.47▼ |
MA100 | 1.60▼ | 1.74▼ | 1.73▼ | 3.18▼ | N/A |
MA200 | 1.69▼ | 1.73▼ | 1.96▼ | 3.61▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | -0.005▼ | -0.019▼ | 0.020▲ | -0.131▼ |
RSI | 44.744▼ | 29.708▼ | 30.704▼ | 31.526▼ | 33.483▼ |
STOCH | 20.833 | 6.853▼ | 9.745▼ | 35.202 | 5.273▼ |
WILL %R | -20.000▲ | -88.889▼ | -92.982▼ | -95.238▼ | -99.405▼ |
CCI | 48.470 | -121.839▼ | -108.622▼ | -226.161▼ | -116.680▼ |
Thursday, February 06, 2025 04:00 PM
HENDERSON, Nev., November 25, 2024--Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio"), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and ...
|
Friday, January 24, 2025 11:35 PM
Analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Zura Bio in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst J. Schimmer forecasts that the company will post ...
|
Friday, January 24, 2025 11:35 PM
Analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for Zura Bio in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst J. Schimmer forecasts that the company will post ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
10/02/25 | 1.66 | 1.66 | 1.49 | 1.51 | 376,719 |
07/02/25 | 1.78 | 1.78 | 1.65 | 1.66 | 307,600 |
06/02/25 | 1.80 | 1.83 | 1.76 | 1.77 | 181,336 |
05/02/25 | 1.76 | 1.86 | 1.71 | 1.78 | 264,600 |
04/02/25 | 1.72 | 1.83 | 1.705 | 1.71 | 195,442 |
03/02/25 | 1.85 | 1.85 | 1.71 | 1.72 | 209,605 |
31/01/25 | 1.77 | 1.91 | 1.73 | 1.88 | 395,663 |
30/01/25 | 1.75 | 1.90 | 1.72 | 1.76 | 3,394,666 |
29/01/25 | 1.61 | 1.80 | 1.61 | 1.73 | 482,432 |
28/01/25 | 1.64 | 1.675 | 1.60 | 1.61 | 385,348 |
|
|
||||
|
|
||||
|
|